We are live on ! Find out more
IPXL

Impax Laboratories, Inc.
IPXL

Delisted

IPXL was delisted on the 4th of May, 2018.

Back to rankings

181 hedge funds and large institutions have $1.45B invested in Impax Laboratories, Inc. in 2014 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 71 increasing their positions, 61 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 18

66% more call options, than puts

Call options by funds: $8.63M | Put options by funds: $5.18M

16% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 61

9% more funds holding

Funds holding: 166 → 181 (+15)

8% more capital invested

Capital invested by funds: $1.34B → $1.45B (+$108M)

Holders
181
Holders Change
+15
Holders Change %
+9.04%
% of All Funds
5.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
34
Increased
71
Reduced
61
Closed
18
Calls
$8.63M
Puts
$5.18M
Net Calls
+$3.44M
Net Calls Change
+$1.9M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$27.7M
2
Millennium Management
Millennium Management
New York
+$11.8M
3
EAM
Eagle Asset Management
Florida
+$10.2M
4
PI
Putnam Investments
Massachusetts
+$9.82M
5
PC
PointState Capital
New York
+$8.75M

Top Sellers

Rank Fund Capital Flow
1
RIM
RS Investment Management
California
-$25.5M
2
Citadel Advisors
Citadel Advisors
Florida
-$18.9M
3
Neuberger Berman Group
Neuberger Berman Group
New York
-$10.5M
4
Franklin Resources
Franklin Resources
California
-$9.51M
5
Renaissance Technologies
Renaissance Technologies
New York
-$9.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
Prudential Financial
51
Prudential Financial
New Jersey
$4.13M +$27.5K +1,100 +0.7%
Citadel Advisors
52
Citadel Advisors
Florida
$4.01M -$18.9M -756,874 -83%
ACH
53
ArrowMark Colorado Holdings
Colorado
$3.98M +$3.76M +150,500 New
ICAP
54
Independence Capital Asset Partners
Colorado
$3.95M +$3.73M +149,428 New
IHM
55
Iguana Healthcare Management
New York
$3.83M +$2.37M +95,000 +190%
Wells Fargo
56
Wells Fargo
California
$3.73M -$170K -6,796 -5%
California Public Employees Retirement System
57
California Public Employees Retirement System
California
$3.68M +$100K +4,000 +3%
AllianceBernstein
58
AllianceBernstein
Tennessee
$3.56M +$1.43K +57 +0%
Public Sector Pension Investment Board (PSP Investments)
59
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$3.46M -$665K -26,600 -17%
ProShare Advisors
60
ProShare Advisors
Maryland
$3.34M +$2.2M +87,907 +228%
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$3.29M +$10K +400 +0.3%
Connor, Clark & Lunn Investment Management (CC&L)
62
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$3.21M +$895K +35,800 +48%
First Trust Advisors
63
First Trust Advisors
Illinois
$3.09M +$2.93M +117,076 New
CS
64
Credit Suisse
Switzerland
$3.03M -$41.7K -1,669 -1%
AQR Capital Management
65
AQR Capital Management
Connecticut
$2.99M +$267K +10,700 +10%
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$2.9M -$86.8K -3,475 -3%
AC
67
Ascend Capital
California
$2.8M -$1.1M -43,952 -29%
Morgan Stanley
68
Morgan Stanley
New York
$2.73M +$1.04M +41,418 +67%
BG
69
BlackRock Group
United Kingdom
$2.51M -$52.2K -2,089 -2%
State of Tennessee, Department of Treasury
70
State of Tennessee, Department of Treasury
Tennessee
$2.48M +$680K +27,200 +41%
FQ
71
First Quadrant
California
$2.42M – – –
AIG
72
American International Group
New York
$2.33M +$910K +36,399 +70%
LCM
73
Leonard Capital Management
Florida
$2.32M – – –
NC
74
Northpointe Capital
Michigan
$2.3M +$254K +10,150 +13%
PPA
75
Parametric Portfolio Associates
Washington
$2.27M +$62K +2,480 +3%
1 2
3
4 5

IPXL Hedge Fund Activity: Q1 2014 in Review

181 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Impax Laboratories, Inc. (IPXL) for Q1 2014, worth a combined $1.45B — up 8.1% from $1.34B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new IPXL positions and 18 closed out — a net gain of 16 holders — while 71 added to existing stakes and 61 trimmed.

The largest buyer was OrbiMed, adding an estimated $27.7M. The largest seller was RS Investment Management, cutting an estimated $25.5M.

  • 181 institutional investors held Impax Laboratories, Inc. (IPXL) as of Q1 2014, up from 166 in Q4 2013.
  • Funds reported $1.45B of Impax Laboratories, Inc. stock for Q1 2014, up 8.1% quarter-over-quarter.
  • 34 funds opened new Impax Laboratories, Inc. positions in Q1 2014 and 18 closed out, a net change of +16 holders.
  • The largest Impax Laboratories, Inc. buyer in Q1 2014 was OrbiMed, an estimated $27.7M added.
  • The largest Impax Laboratories, Inc. seller in Q1 2014 was RS Investment Management, an estimated $25.5M sold.

Based on aggregated 13F filings for Q1 2014.